Higuchi H, Kamata M, Yoshimoto M, Shimisu T, Hishikawa Y
Department of Neuropsychiatry, Yuri Kumiai General Hospital, Honjyo City, Akita, Japan.
Psychiatry Clin Neurosci. 1999 Feb;53(1):91-4. doi: 10.1046/j.1440-1819.1999.00477.x.
Panic attacks meeting the diagnostic criteria for panic disorder (DSM-III-R) were found in nine (20%) of 45 patients suffering chronic schizophrenia for more than 5 years. The scores of the Hamilton Depression Rating Scale and the Simpson Angus Scale were significantly higher in the group of patients with panic attacks. They also tended to be taking neuroleptics in larger doses than in the other group. The present report suggests that long-term treatment with neuroleptics is closely related to the manifestation of panic attacks in chronic schizophrenia. It also suggests that when panic attacks are seen frequently in patients taking high doses of neuroleptics, dose reduction of neuroleptics should be considered.
在45例患有慢性精神分裂症5年以上的患者中,有9例(20%)出现了符合惊恐障碍(DSM-III-R)诊断标准的惊恐发作。伴有惊恐发作的患者组中,汉密尔顿抑郁量表和辛普森·安格斯量表的得分显著更高。他们服用抗精神病药物的剂量也往往比另一组更大。本报告表明,抗精神病药物的长期治疗与慢性精神分裂症中惊恐发作的表现密切相关。它还表明,当服用高剂量抗精神病药物的患者频繁出现惊恐发作时,应考虑减少抗精神病药物的剂量。